Noveus Capital is a dynamic venture capital firm that primarily focuses on early-stage investments, including pre-seed, seed, and Series A rounds. The firm invests across various sectors and geographies, with typical investment sizes ranging from $500,000 to $10 million. Their portfolio spans a diverse array of industries, reflecting their broad investment mandate.
Notable portfolio companies include Senti Biosciences, which has raised $105 million, and Impossible Metals with $10.1 million raised. Key partners at Noveus Capital bring extensive experience from leading firms and startups. The firm prides itself on its hands-on investment philosophy, offering unique value-add services such as strategic guidance, operational support, and access to a robust network of industry experts to help portfolio companies scale effectively.
Noveus Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies12
Current Portfolio Count11
Top Investment Stages
Seed7 (58.3%)
Pre-Seed3 (25.0%)
Series A1 (8.3%)
Series B1 (8.3%)
Stage Mix
Seed 58%Pre-Seed 25%Series A 8%Series B 8%
Concentration shown as share of disclosed investments by stage.
